BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16837204)

  • 21. Antimalarial and antitrypanosomal activity of a series of amide and sulfonamide derivatives of a 2,5-diaminobenzophenone.
    Altenkämper M; Bechem B; Perruchon J; Heinrich S; Mädel A; Ortmann R; Dahse HM; Freunscht E; Wang Y; Rath J; Stich A; Hitzler M; Chiba P; Lanzer M; Schlitzer M
    Bioorg Med Chem; 2009 Nov; 17(22):7690-7. PubMed ID: 19819706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-activity relationship and molecular modelling studies of quinazolinedione derivatives MMV665916 as potential antimalarial agent.
    Mourot L; Schmitt M; Mouray E; Spichty M; Florent I; Albrecht S
    Bioorg Med Chem; 2021 Dec; 51():116513. PubMed ID: 34798379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative molecular field analysis and molecular docking studies on novel aryl chalcone derivatives against an important drug target cysteine protease in Plasmodium falciparum.
    Thillainayagam M; Anbarasu A; Ramaiah S
    J Theor Biol; 2016 Aug; 403():110-128. PubMed ID: 27185536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonbisphosphonate inhibitors of Plasmodium falciparum FPPS/GGPPS.
    Kabeche S; Aida J; Akther T; Ichikawa T; Ochida A; Pulkoski-Gross MJ; Smith M; Humphries PS; Yeh E
    Bioorg Med Chem Lett; 2021 Jun; 41():127978. PubMed ID: 33766764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structurally simple farnesyltransferase inhibitors arrest the growth of malaria parasites.
    Glenn MP; Chang SY; Hucke O; Verlinde CL; Rivas K; Hornéy C; Yokoyama K; Buckner FS; Pendyala PR; Chakrabarti D; Gelb M; Van Voorhis WC; Sebti SM; Hamilton AD
    Angew Chem Int Ed Engl; 2005 Aug; 44(31):4903-6. PubMed ID: 16007716
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug discovery studies on quinoline-based derivatives as potential antimalarial agents.
    Sharma R; Patil S; Maurya P
    SAR QSAR Environ Res; 2014; 25(3):189-203. PubMed ID: 24601770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum.
    Qidwai T; Yadav DK; Khan F; Dhawan S; Bhakuni RS
    Curr Pharm Des; 2012; 18(37):6133-54. PubMed ID: 22670592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. QSAR analyses on avian influenza virus neuraminidase inhibitors using CoMFA, CoMSIA, and HQSAR.
    Zheng M; Yu K; Liu H; Luo X; Chen K; Zhu W; Jiang H
    J Comput Aided Mol Des; 2006 Sep; 20(9):549-66. PubMed ID: 17103017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. QSAR study on the antimalarial activity of Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitors.
    Hou X; Chen X; Zhang M; Yan A
    SAR QSAR Environ Res; 2016; 27(2):101-24. PubMed ID: 26911561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-activity relationships of novel anti-malarial agents. Part 6: N-(4-arylpropionylamino-3-benzoylphenyl)-[5-(4-nitrophenyl)-2-furyl]acrylic acid amides.
    Wiesner J; Fucik K; Kettler K; Sakowski J; Ortmann R; Jomaa H; Schlitzer M
    Bioorg Med Chem Lett; 2003 May; 13(9):1539-41. PubMed ID: 12699750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitors of farnesyltransferase: 5-arylacryloylaminobenzophenones show antimalarial activity.
    Wiesner J; Ortmann R; Mitsch A; Wissner P; Sattler I; Jomaa H; Schlitzer M
    Pharmazie; 2003 Apr; 58(4):289-90. PubMed ID: 12749417
    [No Abstract]   [Full Text] [Related]  

  • 32. QSAR studies on benzothiophene derivatives as Plasmodium falciparum N-myristoyltransferase inhibitors: Molecular insights into affinity and selectivity.
    Garcia ML; de Oliveira AA; Bueno RV; Nogueira VHR; de Souza GE; Guido RVC
    Drug Dev Res; 2022 Apr; 83(2):264-284. PubMed ID: 32045013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CoMFA and CoMSIA studies on aryl carboxylic acid amide derivatives as dihydroorotate dehydrogenase (DHODH) inhibitors.
    Vyas VK; Ghate M
    Curr Comput Aided Drug Des; 2012 Dec; 8(4):271-82. PubMed ID: 22242798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) of thiazolone derivatives as hepatitis C virus NS5B polymerase allosteric inhibitors.
    Lei B; Du J; Li S; Liu H; Ren Y; Yao X
    J Comput Aided Mol Des; 2008 Oct; 22(10):711-25. PubMed ID: 18716715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of a novel lead structure for anti-malarials.
    Wiesner J; Wissner P; Dahse HM; Jomaa H; Schlitzer M
    Bioorg Med Chem; 2001 Mar; 9(3):785-92. PubMed ID: 11310613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. QSAR study on tetrahydroquinoline analogues as plasmodium protein farnesyltransferase inhibitors: a comparison of rationales of malarial and mammalian enzyme inhibitory activities for selectivity.
    Gupta MK; Prabhakar YS
    Eur J Med Chem; 2008 Dec; 43(12):2751-67. PubMed ID: 18329140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. QSAR and pharmacophore modeling of natural and synthetic antimalarial prodiginines.
    Singh B; Vishwakarma RA; Bharate SB
    Curr Comput Aided Drug Des; 2013 Sep; 9(3):350-9. PubMed ID: 24010933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery and preliminary structure-activity relationship studies on tecomaquinone I and tectol as novel farnesyltransferase and plasmodial inhibitors.
    Cadelis MM; Bourguet-Kondracki ML; Dubois J; Valentin A; Barker D; Copp BR
    Bioorg Med Chem; 2016 Jul; 24(14):3102-7. PubMed ID: 27240468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Second generation tetrahydroquinoline-based protein farnesyltransferase inhibitors as antimalarials.
    Bendale P; Olepu S; Suryadevara PK; Bulbule V; Rivas K; Nallan L; Smart B; Yokoyama K; Ankala S; Pendyala PR; Floyd D; Lombardo LJ; Williams DK; Buckner FS; Chakrabarti D; Verlinde CL; Van Voorhis WC; Gelb MH
    J Med Chem; 2007 Sep; 50(19):4585-605. PubMed ID: 17722901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.